Methods for increasing efficacy of FOLR1 cancer therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11135305
APP PUB NO 20180200383A1
SERIAL NO

15807831

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods to improve the success of cancer therapies that target the human folate receptor 1 are provided. Kits comprising reagent useful in the methods are further provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • IMMUNOGEN, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carrigan, Christina N Belmont, US 17 218
Ladd, Sharron Burlington, US 10 128
Payne, Gillian Waban, US 29 482
Whiteman, Kathleen R Wilmington, US 8 137

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 5, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 5, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 5, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00